{"issuance_frequency":"","notes_translated":{"fr":"Les lignes directrices s'adressent aux personnes qui présentent une demande d'autorisation d'essais cliniques pour des médicaments et des instruments médicaux liés à la COVID-19 au titre de l'Arrêté d'urgence (AU) no 2.","en":"The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under Interim Order (IO) No. 2. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"75f3b182-3bb9-4ab3-8236-93231e984615","metadata_created":"2021-05-28T15:11:02.760557","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-05-28T15:11:02.760564","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-05-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["document d'orientation","ordonnance provisoire","n ° 2","coronavirus","COVID-19","essais cliniques","médicament","dispositif médical","autorisation d'essai clinique","approbation du médicament"],"en":["guidance document","Interim Order","IO No.2","coronavirus","COVID-19","clinical trials","drug","medical device","clinical trial authorization","drug approval"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Demandes d'essais cliniques de médicaments et d'instruments médicaux liés à la COVID-19 au titreau titre de l'arrêté d'urgence : Avis de mise à jour des lignes directrices","en":"Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"75f3b182-3bb9-4ab3-8236-93231e984615","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ebefd30b-eaa6-48df-8c8b-3c50874016bb","related_relationship":"","name_translated":{"fr":"Demandes d'essais cliniques de médicaments et d'instruments médicaux liés à la COVID-19 au titreau titre de l'arrêté d'urgence : Avis de mise à jour des lignes directrices","en":"Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents","language":["en"],"created":"2021-05-28T15:11:02.874231","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/interim-order-2-clinical-trials-medical-devices-drugs/guidance-documents-notice.html","last_modified":null,"position":0,"revision_id":"d9eacdee-8a51-4594-b341-4aee836c0b4c","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"75f3b182-3bb9-4ab3-8236-93231e984615","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d4e06172-2832-4391-ab4f-52f882f69dc0","related_relationship":"","name_translated":{"fr":"Demandes d'essais cliniques de médicaments et d'instruments médicaux liés à la COVID-19 au titreau titre de l'arrêté d'urgence : Avis de mise à jour des lignes directrices","en":"Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents","language":["fr"],"created":"2021-05-28T15:11:02.874236","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/arrete-urgence-no-2-cliniques-instruments-medicaux-drogues/note-explanative/lignes-directrices-avis.html","last_modified":null,"position":1,"revision_id":"d9eacdee-8a51-4594-b341-4aee836c0b4c","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-05-03 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"75f3b182-3bb9-4ab3-8236-93231e984615","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under Interim Order (IO) No. 2. ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents","revision_id":"d9eacdee-8a51-4594-b341-4aee836c0b4c"}